The Na+/Ca2+ exchanger inhibitor KB-R7943 activates large-conductance Ca2+-activated K+ channels in endothelial and vascular smooth muscle cells

Guo Hua Liang, Ji Aee Kim, Geun Hee Seol, Shinkyu Choi, Suk Hyo Suh

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The effect of the selective inhibitor of Na+/Ca2+ exchanger (NCX), KB-R7943, on large-conductance Ca2+-activated K+ (BKCa) channels was examined in cultured human umbilical vein endothelial cells (HUVECs) and freshly isolated mouse aortic smooth muscle cells (MASMCs). In voltage-clamped cells, KB-R7943 reversibly activated BKCa currents in HUVECs and MASMCs. The EC50 of KB-R7943 for BKCa current activation in HUVECs was determined to be 6.78 ± 0.7 μM. In inside-out and outside-out patches, KB-R7943 markedly increased BKCa channel activity and slightly decreased single channel current amplitudes. In inside-out patches, KB-R7943 shifted the relationship between [Ca2+]i and open probability (Po) to the left; the [Ca2+]i required to evoke half-maximal activation changed from 1220 ± 68 nM (in the absence of KB-R7943) to 620 ± 199 nM (in the presence of 10 μM KB-R7943). In addition, KB-R7943 shifted the relationship between membrane potential and Po to the left; the membrane potential to evoke half-maximal activation changed from 76.86 ± 1.09 mV (in the absence of KB-R7943) to 49.62 ± 2.55 mV (in the presence of 10 μM KB-R7943). In conclusion, KB-R7943 was found to act as a potent BKCa channel activator, which increases the sensitivity of BKCa channels to cytosolic free Ca2+ and membrane potential, and thereby BKCa channel activity. These results should be considered when KB-R7943 is used as NCX blocker.

Original languageEnglish
Pages (from-to)35-41
Number of pages7
JournalEuropean Journal of Pharmacology
Volume582
Issue number1-3
DOIs
Publication statusPublished - 2008 Mar 17
Externally publishedYes

Fingerprint

Calcium-Activated Potassium Channels
Vascular Smooth Muscle
Smooth Muscle Myocytes
Human Umbilical Vein Endothelial Cells
Membrane Potentials
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate

Keywords

  • Endothelial cells
  • KB-R7943
  • Large-conductance Ca-activated K channels

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

The Na+/Ca2+ exchanger inhibitor KB-R7943 activates large-conductance Ca2+-activated K+ channels in endothelial and vascular smooth muscle cells. / Liang, Guo Hua; Kim, Ji Aee; Seol, Geun Hee; Choi, Shinkyu; Suh, Suk Hyo.

In: European Journal of Pharmacology, Vol. 582, No. 1-3, 17.03.2008, p. 35-41.

Research output: Contribution to journalArticle

@article{c31740ad48174c91b592b71814694c48,
title = "The Na+/Ca2+ exchanger inhibitor KB-R7943 activates large-conductance Ca2+-activated K+ channels in endothelial and vascular smooth muscle cells",
abstract = "The effect of the selective inhibitor of Na+/Ca2+ exchanger (NCX), KB-R7943, on large-conductance Ca2+-activated K+ (BKCa) channels was examined in cultured human umbilical vein endothelial cells (HUVECs) and freshly isolated mouse aortic smooth muscle cells (MASMCs). In voltage-clamped cells, KB-R7943 reversibly activated BKCa currents in HUVECs and MASMCs. The EC50 of KB-R7943 for BKCa current activation in HUVECs was determined to be 6.78 ± 0.7 μM. In inside-out and outside-out patches, KB-R7943 markedly increased BKCa channel activity and slightly decreased single channel current amplitudes. In inside-out patches, KB-R7943 shifted the relationship between [Ca2+]i and open probability (Po) to the left; the [Ca2+]i required to evoke half-maximal activation changed from 1220 ± 68 nM (in the absence of KB-R7943) to 620 ± 199 nM (in the presence of 10 μM KB-R7943). In addition, KB-R7943 shifted the relationship between membrane potential and Po to the left; the membrane potential to evoke half-maximal activation changed from 76.86 ± 1.09 mV (in the absence of KB-R7943) to 49.62 ± 2.55 mV (in the presence of 10 μM KB-R7943). In conclusion, KB-R7943 was found to act as a potent BKCa channel activator, which increases the sensitivity of BKCa channels to cytosolic free Ca2+ and membrane potential, and thereby BKCa channel activity. These results should be considered when KB-R7943 is used as NCX blocker.",
keywords = "Endothelial cells, KB-R7943, Large-conductance Ca-activated K channels",
author = "Liang, {Guo Hua} and Kim, {Ji Aee} and Seol, {Geun Hee} and Shinkyu Choi and Suh, {Suk Hyo}",
year = "2008",
month = "3",
day = "17",
doi = "10.1016/j.ejphar.2007.12.021",
language = "English",
volume = "582",
pages = "35--41",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - The Na+/Ca2+ exchanger inhibitor KB-R7943 activates large-conductance Ca2+-activated K+ channels in endothelial and vascular smooth muscle cells

AU - Liang, Guo Hua

AU - Kim, Ji Aee

AU - Seol, Geun Hee

AU - Choi, Shinkyu

AU - Suh, Suk Hyo

PY - 2008/3/17

Y1 - 2008/3/17

N2 - The effect of the selective inhibitor of Na+/Ca2+ exchanger (NCX), KB-R7943, on large-conductance Ca2+-activated K+ (BKCa) channels was examined in cultured human umbilical vein endothelial cells (HUVECs) and freshly isolated mouse aortic smooth muscle cells (MASMCs). In voltage-clamped cells, KB-R7943 reversibly activated BKCa currents in HUVECs and MASMCs. The EC50 of KB-R7943 for BKCa current activation in HUVECs was determined to be 6.78 ± 0.7 μM. In inside-out and outside-out patches, KB-R7943 markedly increased BKCa channel activity and slightly decreased single channel current amplitudes. In inside-out patches, KB-R7943 shifted the relationship between [Ca2+]i and open probability (Po) to the left; the [Ca2+]i required to evoke half-maximal activation changed from 1220 ± 68 nM (in the absence of KB-R7943) to 620 ± 199 nM (in the presence of 10 μM KB-R7943). In addition, KB-R7943 shifted the relationship between membrane potential and Po to the left; the membrane potential to evoke half-maximal activation changed from 76.86 ± 1.09 mV (in the absence of KB-R7943) to 49.62 ± 2.55 mV (in the presence of 10 μM KB-R7943). In conclusion, KB-R7943 was found to act as a potent BKCa channel activator, which increases the sensitivity of BKCa channels to cytosolic free Ca2+ and membrane potential, and thereby BKCa channel activity. These results should be considered when KB-R7943 is used as NCX blocker.

AB - The effect of the selective inhibitor of Na+/Ca2+ exchanger (NCX), KB-R7943, on large-conductance Ca2+-activated K+ (BKCa) channels was examined in cultured human umbilical vein endothelial cells (HUVECs) and freshly isolated mouse aortic smooth muscle cells (MASMCs). In voltage-clamped cells, KB-R7943 reversibly activated BKCa currents in HUVECs and MASMCs. The EC50 of KB-R7943 for BKCa current activation in HUVECs was determined to be 6.78 ± 0.7 μM. In inside-out and outside-out patches, KB-R7943 markedly increased BKCa channel activity and slightly decreased single channel current amplitudes. In inside-out patches, KB-R7943 shifted the relationship between [Ca2+]i and open probability (Po) to the left; the [Ca2+]i required to evoke half-maximal activation changed from 1220 ± 68 nM (in the absence of KB-R7943) to 620 ± 199 nM (in the presence of 10 μM KB-R7943). In addition, KB-R7943 shifted the relationship between membrane potential and Po to the left; the membrane potential to evoke half-maximal activation changed from 76.86 ± 1.09 mV (in the absence of KB-R7943) to 49.62 ± 2.55 mV (in the presence of 10 μM KB-R7943). In conclusion, KB-R7943 was found to act as a potent BKCa channel activator, which increases the sensitivity of BKCa channels to cytosolic free Ca2+ and membrane potential, and thereby BKCa channel activity. These results should be considered when KB-R7943 is used as NCX blocker.

KW - Endothelial cells

KW - KB-R7943

KW - Large-conductance Ca-activated K channels

UR - http://www.scopus.com/inward/record.url?scp=39149125440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149125440&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2007.12.021

DO - 10.1016/j.ejphar.2007.12.021

M3 - Article

C2 - 18237728

AN - SCOPUS:39149125440

VL - 582

SP - 35

EP - 41

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -